Spaventa Andrew's Form 4 filing
Singular Genomics Systems, Inc. (OMIC) · filed Nov 20, 2023
- Accession no.
- 0001209191-23-056071
- Filed
- Nov 20, 2023, 4:31 PM ET
- Trade date
- Nov 16-17, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $49.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spaventa AndrewCIK 0001859701 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | PPurchaseAcquired | +43,468 | $0.4108 | +$17,856.65 | 3,986,206 | Indirect | |
| Nov 17, 2023 | Common Stock | PPurchaseAcquired | +75,000 | $0.4234 | +$31,755 | 4,061,206 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.